Literature DB >> 2358304

Inv(14) with distal breakpoint in 14q32.1 in three cases of T cell lymphoma.

B Schlegelberger1, A C Feller, H H Wacker, J Lohmeyer, W Grote.   

Abstract

The distal breakpoint of inv(14) in T cell clones, established from patients with ataxia telangiectasia, lies outside the immunoglobulin heavy chain gene locus on 14q32.3, and more proximal to the centromere than the distal breakpoint of inv(14) in the T cell lymphoma cell line SUP-T1. We report 3 cases of T cell lymphoma cytogenetically showing the same type of inv(14) as the AT T cell clones. All 3 cases express a similar immunophenotype, which is that of peripheral T lymphocytes with phenotypic remnants of thymic or postthymic lymphoblasts. This finding provides evidence that this type of inv(14) is involved in the malignant transformation of mature T lymphocytes.

Entities:  

Mesh:

Year:  1990        PMID: 2358304     DOI: 10.1007/bf00276328

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  The mechanism of chromosome 14 inversion in a human T cell lymphoma.

Authors:  R Baer; A Forster; T H Rabbitts
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

2.  Abnormalities of chromosome 14 at band 14q11 in Japanese patients with adult T-cell leukemia.

Authors:  N Sadamori; M Kusano; K Nishino; M Tagawa; E Yao; Y Yamada; T Amagasaki; K Kinoshita; M Ichimaru
Journal:  Cancer Genet Cytogenet       Date:  1985-07

3.  Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors.

Authors:  R Baer; K C Chen; S D Smith; T H Rabbitts
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

4.  Human immunoglobulin heavy chain genes map to a region of translocations in malignant B lymphocytes.

Authors:  I R Kirsch; C C Morton; K Nakahara; P Leder
Journal:  Science       Date:  1982-04-16       Impact factor: 47.728

5.  A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci.

Authors:  C T Denny; Y Yoshikai; T W Mak; S D Smith; G F Hollis; I R Kirsch
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

6.  Common region on chromosome 14 in T-cell leukemia and lymphoma.

Authors:  F Hecht; R Morgan; B K Hecht; S D Smith
Journal:  Science       Date:  1984-12-21       Impact factor: 47.728

7.  Lymphocyte malignancy and chromosome 14: structural aberrations involving band q11.

Authors:  N Clare; D Boldt; G Messerschmidt; P Zeltzer; K Hansen; L Manhoff
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

8.  The chromosome breakpoint at 14q32 in an ataxia telangiectasia t(14;14) T cell clone is different from the 14q32 breakpoint in Burkitts and an inv(14) T cell lymphoma.

Authors:  A A Kennaugh; S V Butterworth; R Hollis; R Baer; T H Rabbitts; A M Taylor
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

9.  Molecular characterization of ataxia telangiectasia T cell clones. II. The clonal inv(14) in ataxia telangiectasia differs from the inv(14) in T cell lymphoma.

Authors:  F Zhang; M H Stern; G Thomas; A Aurias
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

10.  Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms.

Authors:  C M Croce; M Isobe; A Palumbo; J Puck; J Ming; D Tweardy; J Erikson; M Davis; G Rovera
Journal:  Science       Date:  1985-03-01       Impact factor: 47.728

View more
  2 in total

1.  Chromosome walking on the TCL1 locus involved in T-cell neoplasia.

Authors:  L Virgilio; M Isobe; M G Narducci; P Carotenuto; B Camerini; N Kurosawa; C M Croce; G Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

2.  Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.

Authors:  H Nowotny; H Karlic; H Grüner; J Hirsch; M Vesely; A Nader; R Heinz
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.